A systematic review and meta-analysis of metalloproteinases in patients with Alzheimer's disease and mild cognitive impairment. | ClinicLens
BackgroundVarious studies have reported altered expression of metalloproteinases in Alzheimer's disease (AD); however, expression profiles of each metalloproteinase during cognitive decline have not yet been fully characterized.ObjectiveThe purpose of this systematic review
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.